*Human Pai 1 Recombinant Glycosylated Stable Mutant

Select this product for Molecular Innovations name, Human PAI-1 (Glycosylated - stable mutant) and product number, GLYCPAI.Human PAI-1 Recombinant Glycosylated Stable Mutant from Innovative Research has been recombinantly produced in insect cell culture and purified by affinity chromatography. This is a Frozen liquid buffered in 0.05M Sodium Phosphate; 0.1M NaCl; 1mM EDTA; pH 6.6 and a purity of >95% as determined by SDS-PAGE. More Details: Species: Human Target: PAI-1 Purification Method: Affinity purified Purity: >95% as determined by SDS-PAGE Analysis Source: Insect cell culture Storage Conditions: -70 C Additional Information: Glycolyslated human PAI-1 recombinantly produced in insect cells. Molecular weight of 46,000 Da. The stable mutant contains four mutations (K154T, Q319L, M354I and N150H) to confer additional stability to the otherwise labile molecule. This product can be used as a control in applications like ELISA and Western Blot. It can be used for a wide range of in vitro applications, including affinity purification, blocking, fibrinolysis, hypertension studies, inhibition, plasminogen activation, protein-protein interactions, receptor binding, and more. At Innovative Research, we provide reliable, consistent products that deliver reliable, consistent results.